Activating c-KIT-Mutation in metastatic malignant Melanoma of the Temple

被引：0
|
作者：
Schaefer-Roosen, J. [1 ]
Kirschke, J. [1 ]
Hyun, J. [1 ]
Tigges, C. [1 ]
Kreuter, A. [1 ]
机构：
[1] HELIOS St Elisabeth Hosp Oberhausen, Klin Dermatol Venerol & Allergol, Oberhausen, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2013年 / 11卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1118 / 1118
页数：1
相关论文
共 50 条
  • [21] Metastatic malignant melanoma
    Shimamoto, C
    Hirata, I
    Umegaki, E
    Takiuchi, H
    Katsu, K
    GASTROINTESTINAL ENDOSCOPY, 2002, 56 (03) : 416 - 416
  • [22] Metastatic malignant melanoma
    Meric, JB
    Rixe, O
    Khayat, D
    DRUGS OF TODAY, 2003, 39 : 17 - 38
  • [23] METASTATIC MALIGNANT MELANOMA
    MCNEER, G
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1966, 195 (11): : 978 - &
  • [24] Metastatic malignant melanoma
    Markovic, S. N.
    Erickson, L. A.
    Flotte, T. J.
    Kottschade, L. A.
    Mcwilliams, R. R.
    Jakub, J. W.
    Farley, D. R.
    Tran, N. V.
    Schild, S. E.
    Olivier, K. R.
    Vuk-Pavlovic, S.
    Sekulic, A.
    Weenig, R. H.
    Pulido, J. S.
    Quevedo, J. F.
    Vile, R. G.
    Wiseman, G. A.
    Stoian, I.
    Pittelkow, M. R.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2009, 144 (01): : 1 - 26
  • [25] Expression of c-KIT in malignant melanoma subtypes: An immunohistochemical study
    Yaman, B.
    Soyluer, U.
    Akalin, T.
    VIRCHOWS ARCHIV, 2017, 471 : S125 - S125
  • [26] Emergence of CTNNB1 mutation at acquired resistance to KIT inhibitor in metastatic melanoma
    Cho, J.
    Kim, S. Y.
    Kim, Y. J.
    Sim, M. H.
    Kim, S. T.
    Kim, N. K. D.
    Kim, K.
    Park, W.
    Kim, J. H.
    Jang, K. -T.
    Lee, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (10): : 1247 - 1252
  • [27] Emergence of CTNNB1 mutation at acquired resistance to KIT inhibitor in metastatic melanoma
    J. Cho
    S. Y. Kim
    Y. J. Kim
    M. H. Sim
    S. T. Kim
    N. K. D. Kim
    K. Kim
    W. Park
    J. H. Kim
    K.-T. Jang
    J. Lee
    Clinical and Translational Oncology, 2017, 19 : 1247 - 1252
  • [28] Characterization of S628N A Novel KIT Mutation Found in a Metastatic Melanoma
    Vita, Marina
    Tisserand, Julie C.
    de Beauchene, Isaure Chauvot
    Panel, Nicolas
    Tchertanov, Luba
    Agopian, Julie
    Mescam-Mancini, Lenaig
    Fouet, Bernard
    Fournier, Beatrice
    Dubreuil, Patrice
    Bertucci, Francois
    De Sepulveda, Paulo
    JAMA DERMATOLOGY, 2014, 150 (12) : 1345 - 1349
  • [29] KIT IS A THERAPEUTIC TARGET IN MALIGNANT MELANOMA
    不详
    CANCER DISCOVERY, 2011, 1 (02) : 96 - 96
  • [30] KIT as a Therapeutic Target in Metastatic Melanoma
    Carvajal, Richard D.
    Antonescu, Cristina R.
    Wolchok, Jedd D.
    Chapman, Paul B.
    Roman, Ruth-Ann
    Teitcher, Jerrold
    Panageas, Katherine S.
    Busam, Klaus J.
    Chmielowski, Bartosz
    Lutzky, Jose
    Pavlick, Anna C.
    Fusco, Anne
    Cane, Lauren
    Takebe, Naoko
    Vemula, Swapna
    Bouvier, Nancy
    Bastian, Boris C.
    Schwartz, Gary K.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (22): : 2327 - 2334
12345